Tag: LifeSciences
Patenting genetic innovation – lessons from REGENXBIO v Sarepta
As gene therapy technologies continue to reshape modern medicine, patent law increasingly faces a difficult task. Courts must distinguish products of nature from genuine biological engineering. They frequently decide whether inventions involving genetic material represent technological innovation or merely identify naturally occurring biological features.
